196 related articles for article (PubMed ID: 4677056)
1. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
Duhault J; Boulanger M; Tisserand F; Bergi L
Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
[No Abstract] [Full Text] [Related]
2. Glypentide: a new hypoglycaemic agent.
Morell J
Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
[No Abstract] [Full Text] [Related]
3. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
Jorgensen KD
Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
[TBL] [Abstract][Full Text] [Related]
4. Insulinotropic action of a new sulfonylurea: gliclazide.
Malaisse WJ; Leclercq-Meyer V
Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
[No Abstract] [Full Text] [Related]
5. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
[No Abstract] [Full Text] [Related]
6. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
7. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
Jorgensen KD
Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
[TBL] [Abstract][Full Text] [Related]
8. Special pharmacology of the new sulfonylurea glimepiride.
Geisen K
Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
[TBL] [Abstract][Full Text] [Related]
9. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
10. The pharmacology and metabolism of oral antidiabetic drugs.
Bänder A
Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
[No Abstract] [Full Text] [Related]
11. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
12. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
13. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
14. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
Tettenborn D
Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
[No Abstract] [Full Text] [Related]
15. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
[No Abstract] [Full Text] [Related]
16. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
Sánchez-Casals MS; Morell-Mestre J
Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
[No Abstract] [Full Text] [Related]
17. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
18. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
[No Abstract] [Full Text] [Related]
19. [Extrapancreatic effects of oral sulfonylureas].
Beyer J; Cordes U; Krall H; Rosak C; Schöffling K
Verh Dtsch Ges Inn Med; 1971; 77():539-43. PubMed ID: 5155894
[No Abstract] [Full Text] [Related]
20. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
Loubatières A; Mariani MM; Ribes G; Alric R; Agot H
Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
